Intellectual Property Law360 provides breaking news and analysis on IP law. Coverage includes high-stakes cases involving patents, copyrights, trademarks, trade secrets, and other forms of IP, as well as policy developments and licensing deals.

Sign up for a 7-day FREE trial today!

Latest News in Intellectual Property

• January 14, 2026

  McConaughey Not 'Alright Alright Alright' With AI Fakes

  Actor Matthew McConaughey's series of trademarks on audio and video of him saying iconic phrases like "alright alright alright" are drawing appreciation from intellectual property attorneys who see them as an attempt to protect against the unauthorized artificial intelligence-generated use of his voice and likeness, but the effectiveness of the tactic may be limited.

• January 14, 2026

  Judge Asks If Execs 'Blindsided' Truist With Mass Exodus

  A North Carolina business judge on Wednesday repeatedly returned to whether three former executives who led Truist's real estate finance arm ever revealed to the bank that they were in "secret" talks to join a competitor and bring dozens of their colleagues with them, signaling he'd let a jury decide if the mass exodus is to blame for the business's alleged losses.

• January 14, 2026

  Google Ex-Staffer Attys In 'Grave Danger' Of Testimony Misstep

  A California federal judge appeared open Wednesday to letting prosecutors introduce previously suppressed evidence from the FBI's interview with an ex-Google engineer accused of stealing trade secrets, telling defense counsel that their efforts to paint Google and the government as in cahoots raised a "grave danger" he'd allow the evidence.

• January 14, 2026

  BOE Settles Display Patent Suits As Other Remains At Trial

  Chinese display maker BOE Technology Group Co. has settled two Eastern District of Texas patent suits brought by Optronic Sciences LLC, one of which was set for trial next month, according to a notice the parties filed, while an unrelated BOE patent trial is ongoing in the same court.

• January 14, 2026

  Exasperated Judge Won't Expand Opioid Film Injunction

  BioDelivery Sciences International needed to pursue a contempt order, not an enforcement action, when alleging a 2022 injunction blocking Alvogen's generic version of its Belbuca opioid film should be applied to a new generic application, a Delaware federal judge held in a case where he was already "frustrated (and exhausted)."

See more Intellectual Property news